The spokesman for the scientific committee in charge of the follow-up of Coronavirus pandemic evolution, Dr Djamel Fourar, who, also, serves as the Health Ministry’s manager for prevention, tackled, today, Sunday, January 17th, 2021, several points concerning the vaccination campaign.
Speaking to the National Radio, Dr. Fourar said that no less than 8,000 centers are equipped and ready to start the vaccination campaign against the Coronavirus, scheduled for the current month.
“If necessary, the number of centers mobilized for this campaign can be increased,” underlined the same official.
As long as the “gray areas” are concerned, the spokesperson said that mobile vaccination centers will be deployed there.
Regarding vaccination, the spokesperson for the scientific committee specified that the patient who receives the vaccine should remain at least 30 minutes in the center.
The speaker also reiterated that the vaccines chosen by Algeria are “effective and safe”, stressing that vaccination remains the only solution to stem the spread of coronavirus.
Earlier this morning, Professor Ryad Mehyaoui, member of the scientific committee monitoring the evolution of Covid-19 pandemic in Algeria, commented on the vaccination campaign in Algeria, unveiling, in this sense, the list of the categories of priority and those exempted from the anti-Covid19 vaccine.
As such, the categories that will benefit from the coronavirus vaccine have been determined.
These are, in priority, the bodies of the health sector and other strategic spheres, the elderly, as well as patients with chronic pathologies, according to the Professor.
On the other hand, other fabrics of the society are not concerned with the vaccination operation to wit; “pregnant women, people with an allergy to vaccine components as well as children”, stressed the same official before recalling that the vaccine remains “non-compulsory for citizens”.
For his part, the Head of the Thoracic Illnesses Department of Rouiba Hospital, Professor Abdelbasset, warned people suffering from allergic illnesses about the risk of receiving the vaccine for fear of complications that remain unforeseen for the present time.